Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.

This study was undertaken in five onchocerciasis/lymphatic filariasis (LF) co-endemic local government areas (LGAs) in Plateau and Nasarawa, Nigeria. Annual MDA with ivermectin had been given for 17 years, 8 of which were in combination with albendazole. In 2008, assessments indicated that LF transm...

Full description

Bibliographic Details
Main Authors: Darin S Evans, Kal Alphonsus, Jon Umaru, Abel Eigege, Emmanuel Miri, Hayward Mafuyai, Carlos Gonzales-Peralta, William Adamani, Elias Pede, Christopher Umbugadu, Yisa Saka, Bridget Okoeguale, Frank O Richards
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-09-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4169246?pdf=render
_version_ 1811192114024808448
author Darin S Evans
Kal Alphonsus
Jon Umaru
Abel Eigege
Emmanuel Miri
Hayward Mafuyai
Carlos Gonzales-Peralta
William Adamani
Elias Pede
Christopher Umbugadu
Yisa Saka
Bridget Okoeguale
Frank O Richards
author_facet Darin S Evans
Kal Alphonsus
Jon Umaru
Abel Eigege
Emmanuel Miri
Hayward Mafuyai
Carlos Gonzales-Peralta
William Adamani
Elias Pede
Christopher Umbugadu
Yisa Saka
Bridget Okoeguale
Frank O Richards
author_sort Darin S Evans
collection DOAJ
description This study was undertaken in five onchocerciasis/lymphatic filariasis (LF) co-endemic local government areas (LGAs) in Plateau and Nasarawa, Nigeria. Annual MDA with ivermectin had been given for 17 years, 8 of which were in combination with albendazole. In 2008, assessments indicated that LF transmission was interrupted, but that the MDA had to continue due to the uncertain status of onchocerciasis transmission. Accordingly, assessments to determine if ivermectin MDA for onchocerciasis could be stopped were conducted in 2009.We evaluated nodule, microfilarial (mf) skin snip, and antibody (IgG4 response to OV16) prevalence in adults and children in six sentinel sites where baseline data from the 1990s were available. We applied the 2001 WHO criteria for elimination of onchocerciasis that defined transmission interruption as an infection rate of <0.1% in children (using both skin snip and OV16 antibody) and a rate of infective (L3) blackflies of <0.05%.Among adult residents in sentinel sites, mean mf prevalence decreased by 99.37% from the 1991-1993 baseline of 42.95% (64/149) to 0.27% (2/739) in 2009 (p<0.001). The OV16 seropositivity of 3.52% (26/739) among this same group was over ten times the mf rate. No mf or nodules were detected in 4,451 children in sentinel sites and 'spot check' villages, allowing the exclusion of 0.1% infection rate with 95% confidence. Seven OV16 seropositives were detected, yielding a seroprevalence of 0.16% (0.32% upper 95%CI). No infections were detected in PCR testing of 1,568 Simulium damnosum s.l. flies obtained from capture sites around the six sentinel sites.Interruption of transmission of onchocerciasis in these five LGAs is highly likely, although the number of flies caught was insufficient to exclude 0.05% with 95% confidence (upper CI 0.23%). We suggest that ivermectin MDA could be stopped in these LGAs if similar results are seen in neighboring districts.
first_indexed 2024-04-11T23:46:21Z
format Article
id doaj.art-2dab0611976240dbba16c0f537f44ef0
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-04-11T23:46:21Z
publishDate 2014-09-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-2dab0611976240dbba16c0f537f44ef02022-12-22T03:56:37ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-09-0189e311310.1371/journal.pntd.0003113Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.Darin S EvansKal AlphonsusJon UmaruAbel EigegeEmmanuel MiriHayward MafuyaiCarlos Gonzales-PeraltaWilliam AdamaniElias PedeChristopher UmbugaduYisa SakaBridget OkoegualeFrank O RichardsThis study was undertaken in five onchocerciasis/lymphatic filariasis (LF) co-endemic local government areas (LGAs) in Plateau and Nasarawa, Nigeria. Annual MDA with ivermectin had been given for 17 years, 8 of which were in combination with albendazole. In 2008, assessments indicated that LF transmission was interrupted, but that the MDA had to continue due to the uncertain status of onchocerciasis transmission. Accordingly, assessments to determine if ivermectin MDA for onchocerciasis could be stopped were conducted in 2009.We evaluated nodule, microfilarial (mf) skin snip, and antibody (IgG4 response to OV16) prevalence in adults and children in six sentinel sites where baseline data from the 1990s were available. We applied the 2001 WHO criteria for elimination of onchocerciasis that defined transmission interruption as an infection rate of <0.1% in children (using both skin snip and OV16 antibody) and a rate of infective (L3) blackflies of <0.05%.Among adult residents in sentinel sites, mean mf prevalence decreased by 99.37% from the 1991-1993 baseline of 42.95% (64/149) to 0.27% (2/739) in 2009 (p<0.001). The OV16 seropositivity of 3.52% (26/739) among this same group was over ten times the mf rate. No mf or nodules were detected in 4,451 children in sentinel sites and 'spot check' villages, allowing the exclusion of 0.1% infection rate with 95% confidence. Seven OV16 seropositives were detected, yielding a seroprevalence of 0.16% (0.32% upper 95%CI). No infections were detected in PCR testing of 1,568 Simulium damnosum s.l. flies obtained from capture sites around the six sentinel sites.Interruption of transmission of onchocerciasis in these five LGAs is highly likely, although the number of flies caught was insufficient to exclude 0.05% with 95% confidence (upper CI 0.23%). We suggest that ivermectin MDA could be stopped in these LGAs if similar results are seen in neighboring districts.http://europepmc.org/articles/PMC4169246?pdf=render
spellingShingle Darin S Evans
Kal Alphonsus
Jon Umaru
Abel Eigege
Emmanuel Miri
Hayward Mafuyai
Carlos Gonzales-Peralta
William Adamani
Elias Pede
Christopher Umbugadu
Yisa Saka
Bridget Okoeguale
Frank O Richards
Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
PLoS Neglected Tropical Diseases
title Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
title_full Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
title_fullStr Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
title_full_unstemmed Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
title_short Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
title_sort status of onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central nigeria challenges in coordinating the stop mda decision
url http://europepmc.org/articles/PMC4169246?pdf=render
work_keys_str_mv AT darinsevans statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT kalalphonsus statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT jonumaru statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT abeleigege statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT emmanuelmiri statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT haywardmafuyai statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT carlosgonzalesperalta statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT williamadamani statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT eliaspede statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT christopherumbugadu statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT yisasaka statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT bridgetokoeguale statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision
AT frankorichards statusofonchocerciasistransmissionaftermorethanadecadeofmassdrugadministrationforonchocerciasisandlymphaticfilariasiseliminationincentralnigeriachallengesincoordinatingthestopmdadecision